These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38928259)

  • 1. Quantitative Virus-Associated RNA Detection to Monitor Oncolytic Adenovirus Replication.
    Brachtlova T; Li J; van der Meulen-Muileman IH; Sluiter F; von Meijenfeldt W; Witte I; Massaar S; van den Oever R; de Vrij J; van Beusechem VW
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
    Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
    Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
    Garza-Morales R; Yaddanapudi K; Perez-Hernandez R; Riedinger E; McMasters KM; Shirwan H; Yolcu E; Montes de Oca-Luna R; Gomez-Gutierrez JG
    Cancer Biol Ther; 2018 Mar; 19(3):188-197. PubMed ID: 29252087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.
    Zhang L; Hedjran F; Larson C; Perez GL; Reid T
    Cancer Gene Ther; 2015 Jan; 22(1):17-22. PubMed ID: 25525035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Tumor Effect of a Novel Oncolytic Virus Based on Chimpanzee Adenovirus Type 6].
    Wang Q; Wang YH; Li Y; Xing M; Zhou DM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):71-76. PubMed ID: 35048603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the Antitumor Efficacy of Oncolytic Adenovirus Through Sonodynamic Therapy-Augmented Virus Replication.
    Ding J; Su R; Yang R; Xu J; Liu X; Yao T; Li S; Wang C; Zhang H; Yue Q; Zhan C; Li C; Gao X
    ACS Nano; 2024 Jul; 18(28):18282-18298. PubMed ID: 38953884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.
    Gros A; Puig C; Guedan S; Rojas JJ; Alemany R; Cascallo M
    Mol Ther; 2010 May; 18(5):903-11. PubMed ID: 20179683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors.
    Peerlinck I; Amini-Nik S; Phillips RK; Iggo R; Lemoine NR; Tejpar S; Vassaux G
    Clin Cancer Res; 2008 Oct; 14(19):6187-92. PubMed ID: 18829497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic potential of an E4-deficient adenovirus that can recognize the stabilization of AU-rich element containing mRNA in cancer cells.
    Yanagawa-Matsuda A; Mikawa Y; Habiba U; Kitamura T; Yasuda M; Towfik-Alam M; Kitagawa Y; Minowa K; Shindoh M; Higashino F
    Oncol Rep; 2019 Feb; 41(2):954-960. PubMed ID: 30431137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic adenoviruses for the treatment of brain tumors.
    Gomez-Manzano C; Fueyo J
    Curr Opin Mol Ther; 2010 Oct; 12(5):530-7. PubMed ID: 20886384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Oncolytic Activities of the Telomerase-Specific Replication-Competent Adenovirus Expressing Short-Hairpin RNA against Dicer.
    Machitani M; Sakurai F; Wakabayashi K; Tachibana M; Fujiwara T; Mizuguchi H
    Mol Cancer Ther; 2017 Jan; 16(1):251-259. PubMed ID: 27760834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth.
    Tedcastle A; Illingworth S; Brown A; Seymour LW; Fisher KD
    Mol Ther; 2016 Apr; 24(4):796-804. PubMed ID: 26708004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.